NEW YORK, Nov 7, (Agencies): A recent study examined the potential of low-dose aspirin in reducing the risk of Type 2 diabetes among older adults. LeShan Reid, a resident of Cockeysville, sought medical help at Mercy Medical Center when she noticed irregularities in her health, particularly her uncontrolled diabetes. After a comprehensive evaluation by family nurse practitioner Jenepher Piper, Reid incorporated aspirin into her daily routine.

The study focused on adults aged 65 and above, aiming to verify whether aspirin could have a positive impact on Type 2 diabetes reduction and, consequently, the occurrence of cardiovascular disease in older individuals. According to Piper, the study participants did not have preexisting diabetes or cardiovascular issues.

The findings indicated that those who took a daily dose of 100 mg of aspirin, slightly higher than the standard baby aspirin, experienced a 15% reduced risk of developing Type 2 diabetes. However, a related study revealed that the same group faced a 38% increased risk of bleeding, with no additional benefits in terms of preventing cardiovascular disease.

Although Reid was not within the specific age group studied, her addition of aspirin to her daily regimen has shown positive results in managing her health. Piper explained that Reid's health metrics are excellent, potentially leading to a longer and healthier life with a lower risk of cardiovascular disease.

While the study's findings are intriguing, Piper emphasized the need for further research before considering aspirin as a preventive measure for diabetes.